Biote Corp (BTMD)
5.22
+0.06
(+1.06%)
USD |
NASDAQ |
Nov 05, 16:00
5.22
0.00 (0.00%)
After-Hours: 18:20
Biote Shareholders Equity (Quarterly): -143.34M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -143.34M |
March 31, 2024 | -35.40M |
December 31, 2023 | -29.40M |
September 30, 2023 | -40.53M |
June 30, 2023 | -46.40M |
Date | Value |
---|---|
March 31, 2023 | -48.54M |
December 31, 2022 | -44.46M |
September 30, 2022 | -37.18M |
June 30, 2022 | -24.95M |
December 31, 2021 | 4.125M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-143.34M
Minimum
Jun 2024
4.125M
Maximum
Dec 2021
-44.61M
Average
-38.85M
Median
Shareholders Equity (Quarterly) Benchmarks
American Shared Hospital Services | 26.54M |
Novo Integrated Sciences Inc | 9.956M |
Astrana Health Inc | 678.87M |
Cryo-Cell International Inc | -9.559M |
P3 Health Partners Inc | 166.84M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 92.90M |
Total Liabilities (Quarterly) | 234.55M |
Debt to Equity Ratio | -0.8383 |
Current Ratio | 1.335 |
Net Debt Paydown Yield | -0.28% |